SS-31 (Elamipretide) Dosage Guide
Complete guide to SS-31 (Elamipretide) dosing protocols, administration methods, and safety considerations for research purposes.
Dosage Overview
Dose per Injection
20 mg – 40 mg
Frequency
Once per day
Route
subcutaneous
Cycle Length
4–12 weeks
Reconstitution
Vial Size
50 mg
BAC Water
2.0 ml
Concentration
25,000 mcg/ml
Detailed Dosage Information
Clinical trials have used IV infusions of 0.25mg/kg for acute conditions.
Subcutaneous dosing protocols for research use typically range from 1-5mg daily.
Administration Method
Can be administered IV or subcutaneously. Most clinical research has used IV administration for cardiac conditions.
Research Use Only: All dosage ranges and calculations are derived from published research literature and are provided for educational purposes. These are not prescriptions or medical recommendations. Consult a healthcare professional before any use.
Concentration: 25 mg/ml
Volume to inject: 1.200 ml
Syringe units: 120.0 units — exceeds 1 ml syringe, split into multiple injections
U-100 insulin syringe (100 units = 1 ml). Verify dose with a clinician before injecting.
Pre-filled with SS-31 (Elamipretide) defaults. Adjust values as needed.
Side Effects to Monitor
Generally well-tolerated. Clinical trials reported injection site reactions and occasional headache.
Safety Considerations & Risks
Failed to meet primary endpoints in some heart failure trials. Long-term effects still being studied. Expensive for research use.